| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 325.672 | 88 |
| GSM780708 | Untreated after 4 days (C2_1) | 361.965 | 89 |
| GSM780709 | Untreated after 4 days (C3_1) | 358.392 | 89 |
| GSM780719 | Untreated after 4 days (C1_2) | 374.783 | 89 |
| GSM780720 | Untreated after 4 days (C2_2) | 360.66 | 89 |
| GSM780721 | Untreated after 4 days (C3_2) | 403.272 | 90 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 357.303 | 89 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 357.303 | 89 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 356.36 | 89 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 387.538 | 90 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 376.844 | 89 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 363.981 | 89 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 359.803 | 89 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 385.283 | 90 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 326.877 | 88 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 381.927 | 89 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 337.067 | 88 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 398.468 | 90 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 355.026 | 89 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 386.181 | 90 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 390.733 | 90 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 363.446 | 89 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 382.809 | 89 |